Loading
Cardiosense
Cardiosense is a Chicago-based digital health company focused on precision cardiac care through AI-enabled solutions. Founded in 2020, the company leverages wearable technology, signal processing, and deep learning to detect, monitor, and manage cardiovascular disease non-invasively. With approximately 38 employees, Cardiosense serves the B2B market in the High Tech, HealthTech, and Life Sciences sectors. The company's flagship product, the CardioTag Sensor, is a medical-grade wearable device that reads ECG, PPG, and seismocardiogram data to estimate cardiac filling pressure without a catheter. Cardiosense also offers the Wavesense Platform, an analytics tool for processing physiological data. Their technology aims to enhance early disease detection and improve management of congestive heart failure, ultimately reducing hospitalizations and healthcare costs. Cardiosense targets healthcare providers, including hospitals and clinics, to support clinicians in managing complex cardiovascular diseases with greater precision.
Funding
Every round, secondary, debt facility or acquisition involving Cardiosense that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$1M